Company Overview

Orbis Biosciences, Inc. is a global leader in precision particle engineering technology for the pharmaceutical and life sciences industries. Their patented technology enables controlled release of active ingredients, improving drug efficacy and patient outcomes. With a focus on innovation and collaboration, Orbis is dedicated to advancing drug delivery solutions for a healthier world.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#39 in Lenexa, KS

#560 in Kansas

#60,641 in US

Lenexa, KS, United States of America

Orbis Biosciences, Inc.

Forward Citations = 6

3 inventors:

Cory Berkland (4 out of 61 patents)

Milind Singh (3 out of 10 patents)

Nathan Dormer (1 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Orbis Biosciences, Inc.. Retrieved from https://idiyas.com/company/orbis-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]